Shareholding disclosure
Santhera Pharmaceuticals Holding AG
Declared position
85.05%
Threshold
Crossed downwards
Timeline
Published
07.11.2020
Transaction
01.11.2020
Voting rights breakdown
Voting rights acquired7.78%
Voting rights sold85.05%
Below threshold0%
Notice details
CategorySingle shareholder
ExchangeXSWX
Notification ID
TAKB500080
Beneficial owner
Santhera Pharmaceuticals Holding AG
Declared address
Santhera Pharmaceuticals Holding AG, Pratteln
also regarding certain sales positions
insider24.ch
Never miss a market signal again
Create a free account
Need more? Discover the Pro plan
Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open